维普期刊资源整合服务平台（V6.5）

70篇 您的检索式：作者名="Hadji P"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	of zoledronic acid on bone mineral density in premenopansal women receiving neoadjuvant or adjuvant ther- apies for HR( + ) breast cancer: the ProBONE II study显示文摘	Hadji P Kauka A Ziller M	2014	Osteoporos Int2014，25，4：	1
2	The impact of menopause on bone,zoledronic acid,and implications for breast can-cer growth and metastasis 显示文摘	Hadji P Coleman R Gnant M	2012	Ann Oncol2012，23，11：	1
3	Assessment by quantitive ultrasonometry of the effects of hormone replacement therapy on bone mss显示文摘	Hadji P Hars O Schuler M	2000	Am J Obstet Gyneeol2000，182，：	1
4	The epidemiology of osteoporosis - Bone Evaluation Study (BEST): an analysis of routine health insur- ance data显示文摘	Hadji P Klein S Gothe H	2013	Dtsch Arztebl Int2013，110，：	1
5	Stiffness index identities patients with osteoporotic fractures better than ultrasound velocity or attenuation alone 显示文摘	Hadji P Hars O Wuster C	1999	Maturitas1999，31，：	1
6	The effect of terip-aratide compared with risedronate on reduction of back pain in postmenopausal women with osteoporotic vertebral frac-tures显示文摘	Hadji P Zanchetta JR Russo L	2012	Osteoporos Int2012，23，：	1
7	Treatment preference for monthly oral ibandronate and weekly oral alendronate in women with postmenopausal osteoporosis:A randomized,crossover study(BALTO Ⅱ)显示文摘	Hadji P Minne H Pfeifer M	2008	Joint Bone Spine2008，75，2：	1
8	Practical guidance for the management of aromatase inhibitor-associated bone loss显示文摘	Hadji P Body JJ Aapro MS	2008	Ann Oncol2008，19，8：	1
9	The effect of teriparatide compared withrisedronate on reduction of back pain inpostmenopausal women with osteoporoticvertebral fractures显示文摘	HADJI P ZANCHETTA JR RUSSO L	2012	OSTEOPOROS Int2012，23，8：	1
10	Management of aromatase inhibitor-associated bone loss in postmenopausal women with breast cancer :practical guidance for prevention and treatment 显示文摘	Hadji P Aapro MS Body JJ	2011	Ann Oncol2011，22，12：	1
11	Treatment of bone metastases before the onset of pain显示文摘	Costa L Lipton A Hadji P	2013	Int J Clin Oncol2013，18，3：	1
12	Management of aromatase inhibitor-associated bone loss in postmenopausal women with breast cancer:practical guidance for prevention and treatment显示文摘	Hadji P Aapro MS Body JJ	2011	Ann Oncol2011，22，12：	1
13	The impact of menopause on bone, zoledronic acid, and implications for breast cancer growth and metastasis 显示文摘	Hadji P Coleman R Gnant M	2012	Anna Oncol2012，23，11：	1
14	The epidemiology of osteoporosisbone evaluation study (BEST):an analysis of routine health insurance data显示文摘	Hadji P Klein S Gothe H	2013	Dtsch Arztebl Int2013，110，4：	1
15	Treatment of bone metastases before the onset of pain显示文摘	Costa L Lipton A Hadji P	2013	Int J Clin Oncol2013，18，3：	1
16	Management of aromataseinhibitor-associated bone loss in postmenopausal women withbreast cancer: practical guidance for prevention and treatment显示文摘	Hadji P Aapro MS Body JJ	2011	Ann Oncol2011，22，12：	1
17	Influence of pregnancy and breast - feeding on quantitative ultrasonometry of bone in postmenopausal women 显示文摘	Hadji P Ziller V Kalder M	2002	Climacteric2002，5，3：	1
18	Sonographic variability of lactating adenoma demonstrated by a longitudinal evaluation of 4 cases显示文摘	Bock K Duda VF Hadji P	2001	Ultraschall Med2001，22，4：	1
19	The Patient' s Anastrozole Compliance to Therapy (PACT) Program: a randomized, in-practice study on the impact of a standardized information program on persistence and compliance to adjuvant endocrine therapy in postmenopausal women with early breast cancer显示文摘	Hadji P Blettner M Harbeck N	2013	Ann Oncol2013，24，6：	1
20	Bisphosphonates:prevention of bone metastases in breast cancer显示文摘	Gnant M Dubsky P Hadji P	2012	Recent Results Cancer Res2012，192，1：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示